Professur für Rheumatologie und Klinische Immunologie

Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance (2022) Yalcin Mutlu M, Wacker J, Tascilar K, Taubmann J, Manger B, Krönke G, Schett G, Simon D Journal article, Letter Clinical Images: Tissue remodeling in autoimmune statin-induced necrotizing autoimmune myopathy (2022) Valor-Mendez L, Manger B, Knitza J, Schmidkonz C, Kleyer A, Schett G Journal article, Editorial Clinical Images: Voriconazole-induced synovitis, enthesitis, and periostitis (2022) Valor-Méndez L, Wacker J, Schett G, Manger B, Fürst J, Strauss R, Kleyer A Journal article CHARACTERIZATION OF RELAPSES IN PATIENTS WITH GIANT CELL ARTERITIS (GCA) PATIENTS- DATA FROM THE REAL-LIFE TREATMENT AND SAFETY (REATS)-GCA COHORT (2022) Schönau V, Corte G, Ott S, Tascilar K, Hartmann F, Manger B, Hellmich B, et al. Conference contribution LONG-TERM HUMORAL RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASE (2022) Tascilar K, Simon D, Kleyer A, Fagni F, Krönke G, Meder C, Dietrich P, et al. Conference contribution PRE-EXPOSURE PROPHYLAXIS FOR SARS-COV-2 INFECTION WITH SUBCUTANEOUS CASIRIVIMAB/IMDEVIMAB IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES. (2022) Fagni F, Schmidt K, Bohr D, Valor L, Hartmann F, Tascilar K, Manger K, et al. Conference contribution Rare meets rarer: anti-synthetase syndrome in a patient with facio-scapulo-humeral muscular dystrophy (2022) Valor-Mendez L, Manger B, Winterholler M, Schett G, Tuerk M, Knitza J Journal article, Letter Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3 (2022) Arora P, Zhang L, Rocha C, Sidarovich A, Kempf A, Schulz S, Cossmann A, et al. Journal article Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab. (2022) Valor-Méndez L, Schett G, Manger B Journal article, Letter Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination (2022) Fagni F, Schmidt K, Bohr D, Valor-Mendez L, Tascilar K, Manger K, Manger B, et al. Journal article, Letter